{
  "retracted": false,
  "timestamp": 1397088000000,
  "updates": [
    {
      "timestamp": 1496016051896,
      "identifier": {
        "doi": "10.1016/j.jconrel.2014.01.020"
      },
      "type": "err"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.jconrel.2012.12.006"
  },
  "journal": "Journal of Controlled Release",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions” [J. Control. Release 169 (2013) 193–203]"
}
